Advertisement
Screener

Niki BioSolutions, Inc. (NIKI) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

2.8 / 5 stars · 68/120 Roast Me

Niki BioSolutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 88.44% for the 12-month period ending 2020-12-31, per its 20-F/A filed 2023-01-17.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2023-01-17

Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month
2020-12-3188.44%
20-F/A · filed 2023-01-17
2020-06-3088.44%
6-K · filed 2021-09-15
2019-12-3195.02%
20-F/A · filed 2023-01-17